Bread Financial™ to Host Investor Day on June 18
COLUMBUS, Ohio, June 04, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that […]
TSX News -
Microbix Advances Test-Ingredient Manufacturing Capabilities
MISSISSAUGA, Ontario, June 04, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, […]
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
Single Infusion of ANX005 30 mg/kg Met Primary Endpoint, Delivering a Highly Statistically Significant and Clinically Meaningful 2.4-fold Improvement in […]
Mobilicom CEO Oren Elkayam to Advocate for Uncrewed Systems at AUVSI’s Hill Day in Washington, D.C.
Elkayam joins other industry leaders in Washington, D.C. to champion regulations supportive of the growth of autonomous technologies Mobilicom to […]
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
PRINCETON, N.J., June 04, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing […]
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
SUNNYVALE, Calif., June 04, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical […]
5E Advanced Materials Provides Organizational Update
HESPERIA, Calif., June 04, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), […]
Universal Stainless Set to Join Russell 2000 and 3000® Indexes
BRIDGEVILLE, Pa., June 04, 2024 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) reported today that it […]
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced […]
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]
